Silvia Zucchini

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 7

Top Topics

Multidrug Resistant

Top Venues

Molecular diagnosis & therapy

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Stefano Cattaneo, Barbara Bettegazzi, Lucia Crippa, Laila Asth, Maria Regoni, Marie Soukupova, Silvia Zucchini, Alessio Cantore, Franca Codazzi, Flavia Valtorta, Michele Simonato
Gene therapy for epilepsy targeting neuropeptide Y and its Y2 receptor to dentate gyrus granule cells. EMBO reports (2024)
Barbara Bettegazzi, Stefano Cattaneo, Michele Simonato, Silvia Zucchini, Marie Soukupova
Viral Vector-Based Gene Therapy for Epilepsy: What Does the Future Hold? Molecular diagnosis & therapy 28 (1) (2023)
Barbara Bettegazzi, Stefano Cattaneo, Michele Simonato, Silvia Zucchini, Marie Soukupova
Viral Vector-Based Gene Therapy for Epilepsy: What Does the Future Hold? Molecular diagnosis & therapy 28 (1) (2023)
Barbara Bettegazzi, Stefano Cattaneo, Michele Simonato, Silvia Zucchini, Marie Soukupova
Viral Vector-Based Gene Therapy for Epilepsy: What Does the Future Hold? Molecular diagnosis & therapy 28 (1) (2023)
Barbara Bettegazzi, Stefano Cattaneo, Michele Simonato, Silvia Zucchini, Marie Soukupova
Viral Vector-Based Gene Therapy for Epilepsy: What Does the Future Hold? Molecular diagnosis & therapy (2023)
Barbara Bettegazzi, Stefano Cattaneo, Michele Simonato, Silvia Zucchini, Marie Soukupova
Viral Vector-Based Gene Therapy for Epilepsy: What Does the Future Hold? Molecular diagnosis & therapy 28 (1) (2023)
Annunziata Guarino, Barbara Bettegazzi, Nimra Aziz, Mario Barbieri, Daniela Bochicchio, Lucia Crippa, Pietro Marino, Maddalena Sguizzato, Marie Soukupova, Silvia Zucchini, Michele Simonato
Low-dose 7,8-Dihydroxyflavone Administration After Status Epilepticus Prevents Epilepsy Development. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 19 (6) (2022)